ReviewFrontiers in medicine2026
Functional redundancy as a stabilizing principle in bacterial communities under antibiotic perturbation: mechanisms, trade-offs, and emerging frameworks.
Review in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Ecological Engineering of the Human Gut Microbiome: A Narrative Review and Framework for Next-Generation Therapeutics.Microorganisms · 2026Review
- Ecological and functional roles of plant microbiomes in environmental detoxification.Frontiers in microbiology · 2026Review
- Synthetic microbial communities for plant growth promotion and soil-borne disease suppression: design principles, mechanisms, and translational challenges.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The widespread use of antibiotics has severely disrupted the structure of microbial communities, but the responses of these communities vary in different environments. Interestingly, even when the species composition changes, some microbial communities can still maintain crucial functions, a phenomenon known as "decoupling of structure and function." Among them, functional redundancy (FR) - the characteristic that multiple microorganisms perform the same ecological function - is the key mechanism for maintaining this stability. This review focuses on how functional redundancy may enhance microbial community resilience under antibiotic perturbation. We first start from the insurance hypothesis and the YAS (yield - acquisition - stress) framework to explain the ecological principles behind functional redundancy, and explain how microorganisms allocate resources and make trade-offs in different environments. We systematically analyze the multi-level defense strategies of microorganisms at five levels, including: ecological niche differentiation at the species level, horizontal transfer of resistance genes at the genetic level, cross-feeding reconstruction of metabolic networks, dormancy strategies at the temporal dimension (seed bank), and population regulation mediated by bacteriophages. Methodologically, we review metatranscriptomic approaches for distinguishing active signals from residual DNA, structural entropy algorithms for inferring FR, and AI-based tools for identifying latent resistance genes. Evidence from ecosystems such as the gut, respiratory tract, soil, and wastewater suggests the broad relevance of functional redundancy, although its stabilizing effect depends on antibiotic type, exposure duration, initial community composition, and ecological context. Finally, we explore the application prospects of this principle in the construction of synthetic communities and the optimization of fecal microbiota transplantation, and point out the evolutionary costs that may accompany maintaining functional redundancy, which is an important challenge that future research needs to address.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.